North American Dermatology Diagnostic Devices Market Size, Share, Competitive Landscape and Trend Analysis Report, by Applications, by Diagnostic Device and, by Treatment Device : Global Opportunity Analysis and Industry Forecast, 2023-2032

Dermatology diagnostic devices are used for treating and diagnosing skin disorders. These devices assist in early detection of skin disorders and improving the skin conditions of the patients. The need of dermatology devices is increasing due to prevalence of skin disorders such as psoriasis, acne, melanoma and others. The desire for youthful appearance and trend of non-invasive aesthetic surgeries would open up new avenues for dermatology diagnostic devices.

The key factors driving the growth of the North American dermatology diagnostic devices includes, rising demand for diagnosis by baby boomers, increasing incidences of skin disorders and need for more dermatologists. However, the factors hindering the growth of the market are lack of awareness, lack of dermatology care and competitive pricing. Technological advancements and awareness about aesthetic procedures will further create opportunities for growth of the dermatology diagnostic devices in North America.

The North American dermatology diagnostic devices market is segmented based on applications, diagnostic device, treatment device and geography. Based on applications, the market is segmented into diagnostic and treatment. The diagnostic device market is further classified into dermatoscope, microscope and imaging techniques whereas the treatment device market is further segmented into liposuction, microdermabrasion, and lasers. Geographically, the North American dermatology diagnostic devices market is segmented into U.S.A., Mexico, Canada, and others.
The leading manufacturers profiled in the report are AMD Global Telemedicine Inc., Michelson Diagnostics Ltd., Nikon Corporation, Carl Zeiss Meditec AG, FEI Company, Fotofinder Systems GMBH, Leica Microsystems, Mela Sciences Inc., Toshiba Medical Systems, Welch Allyn, Verisante Technology Inc., Solta Medical, GE Healthcare, Bruker Corporation, Philips Healthcare, Heine Optotechnik and Siemens Healthcare. Few strategies adopted by the companies are expansion, agreements and mergers to further gain a strong foothold in the market.

KEY BENEFITS FOR STAKEHOLDERS:

• The report offers a detailed analysis of key driving and restraining factors of the North American dermatology diagnostic devices market.
• This report offers an in-depth quantitative analysis of the current market and estimations through 2015-2020, which would assist in identifying the prevailing market opportunities.
• An extensive analysis of dominant market shares for each segment helps in understanding the current status of market.
• An in-depth analysis of key strategies adopted by leading manufacturers to help in the understanding of the competitive scenario.
• The report provides an exhaustive information about new product launches, research and recent developments of the North American dermatology diagnostic devices market.
• Geographically, the North American dermatology diagnostic devices market is segmented into United States, Canada, Mexico.

KEY MARKET SEGMENTS:

North American Dermatology Diagnostic Devices Market By Applications

• Diagnostic
• Treatment

North American Dermatology Diagnostic Devices Market By Diagnostic Device

• Dermatoscope
• Microscope
• Imaging Techniques

North American Dermatology Diagnostic Devices Market By Treatment Device

• Liposuction
• Microdermabrasion
• Lasers

North American Dermatology Diagnostic Devices Market By Geography

• United States
• Mexico
• Canada

  North American Dermatology Diagnostic Devices Market Report Highlights